Novartis Pharmaceuticals Corporation v. Nanjing Noratech Pharmaceutical Co., Limited > Summary
Court Case Number 1:23-cv-00401
Filing Date Apr 10, 2023
Termination Date Jun 17, 2025
Court Delaware District Court
Status Judgment - Judgment on Consent
Appeal2023-2317
JudgesRichard G. Andrews
Plaintiff
Plaintiff Attorneys
11Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Christina A. Schwarz
Novartis
Attorney Name: Christopher E. Loh
Novartis
Attorney Name: Jared L. Stringham
Novartis
Attorney Name: Melinda R. Roberts
Novartis
Attorney Name: Nicholas N. Kallas
Novartis
Attorney Name: Deanne E. Maynard
Novartis
Attorney Name: Daniel A. O'Brien
Venable
Novartis
Attorney Name: Erin K. Belfield
Novartis
Attorney Name: Shannon K. Clark
Defendant Attorneys
10Nanjing Noratech Pharmaceutical Co., Limited
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
Gerbera Therapeutics, Inc.
Attorney Name: Denise S. Kraft
Heyman Enerio Gattuso & Hirzel
Gerbera Therapeutics, Inc.
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
Nanjing Noratech Pharmaceutical Co., Limited
Attorney Name: Don J. Mizerk
Nanjing Noratech Pharmaceutical Co., Limited
Attorney Name: Matthew M. Kamps
Nanjing Noratech Pharmaceutical Co., Limited
Attorney Name: Thomas P. Heneghan
Gerbera Therapeutics, Inc.
Attorney Name: Denise S. Kraft
Heyman Enerio Gattuso & Hirzel
Gerbera Therapeutics, Inc.
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
Gerbera Therapeutics, Inc.
Attorney Name: Avery Hitchcock
Gerbera Therapeutics, Inc.
Attorney Name: Avery Hitchcock
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11058667 | Sacubitril-valsartan dosage regimen for treating heart failure | Jul 13, 2021 |
| 08101659 | Methods of treatment and pharmaceutical composition | Jan 24, 2012 |
